CD68 and prostate carcinoma: Increased CD68+ macrophage count was observed in metastases from the lymph nodes, liver, bladder, rectum, and seminal vesicles in comparison to the corresponding primary tumors collected from 59 prostate cancer patients from the Norway cohort (264).